New England Professional Planning Group Inc. Amarin Corp Plcuk Transaction History

New England Professional Planning Group Inc.

$192 Million
Q1 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2020 May 12, 2020	SELL	$4.0 - $21.53 $37,660 - $202,704	-9,415 Closed	0 $0
Q4 2019 Jan 15, 2020	BUY	$13.94 - $24.12 $131,245 - $227,089	9,415 New	9,415 $202,000

Others Institutions Holding AMRN

# of Institutions

184

Shares Held

87.9M

Call Options Held

528K

Put Options Held

219K

Sarissa Capital Management LP Greenwich, CT

24.9M
Shares

$18.4 Million
3.87% of portfolio
Kynam Capital Management, LP Princeton, NJ

12M
Shares

$8.9 Million
1.12% of portfolio
Dg Capital Management, LLC New York, NY

6.44M
Shares

$4.77 Million
3.54% of portfolio
Eversept Partners, LP New York, NY

6.21M
Shares

$4.6 Million
0.42% of portfolio
Morgan Stanley New York, NY

3.61M
Shares

$2.67 Million
0.0% of portfolio

View Full List

About AMARIN CORP PLCUK

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $298M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

More about AMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Professional Planning Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on New England Professional Planning Group Inc. with notifications on news.

Account